Clinical Impact of the Line Probe Assay and Xpert(®) MTB/RIF Assay in the Presumptive Diagnosis of Drug-Resistant Tuberculosis in Brazil: A Pragmatic Clinical Trial

BACKGROUND: Rapid molecular methods such as the line probe assay (LPA) and Xpert(®) MTB/RIF assay (Xpert) have been recommended by the World Health Organization for drug-resistant tuberculosis (DR-TB) diagnosis. We conducted an interventional trial in DR-TB reference centers in Brazil to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kritski, Afranio, Oliveira, Maria Martha, de Almeida, Isabela Neves, Ramalho, Daniela, Andrade, Monica Kramer de Noronha, Carvalho, Monica, Miranda, Pryscila Fernandes Campino, Dalcolmo, Margareth Pretti, Braga, Jose Ueleres, Brígido, Tania, Mesquita, Eliene, Dias, Claudia, Gambirasio, Aglae, Souza, Joao Baptista, Detjen, Anne, Phillips, Patrick Peter John, Langley, Ivor, Fujiwara, Paula, Squire, Stephen Bertel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Medicina Tropical - SBMT 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932318/
https://www.ncbi.nlm.nih.gov/pubmed/35239898
http://dx.doi.org/10.1590/0037-8682-0191-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932318/
https://www.ncbi.nlm.nih.gov/pubmed/35239898
http://dx.doi.org/10.1590/0037-8682-0191-2021

Ejemplares similares